Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
about
Redox Control of Multidrug Resistance and Its Possible Modulation by AntioxidantsDevelopment, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceNeoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancerBlood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative DiseasesAtypical cell populations associated with acquired resistance to cytostatics and cancer stem cell features: the role of mitochondria in nuclear encapsulationMeta-analytic support vector machine for integrating multiple omics data.ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approachesLow-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor.GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancerARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.Role of AKT signaling in DNA repair and clinical response to cancer therapy.Lost in Translation: Regulation of ABCG2 Expression in Human Embryonic Stem CellsFunctional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.Regulation of ABC transporters at the blood-brain barrier.Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cellsThe green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatinExpression Data Analysis for the Identification of Potential Biomarker of Pregnancy Associated Breast Cancer.Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2.Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.Role of Human Corneal Stroma-Derived Mesenchymal-Like Stem Cells in Corneal Immunity and Wound Healing.Breast cancer resistance protein (Bcrp) and the testis--an unexpected turn of events.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.ABCG2-overexpressing S1-M1-80 cell xenografts in nude mice keep original biochemistry and cell biological propertiesTumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2.ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.RNA interference in head and neck oncology.Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance via NO-Enhanced Chemosensitization.MiR-328 May be Considered as an Oncogene in Human Invasive Breast Carcinoma.Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.MicroRNAs Involved in Anti-Tumour Immunity.Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer.Regulation of breast cancer stem cell features.Design of inhibitors of BCRP/ABCG2.
P2860
Q26765805-255E01DD-A46F-4DD4-9995-29A1B25EDBBEQ26778957-6E9F6DE8-C291-4CD8-A5A5-4CAA28CEDCE8Q26865927-AD8AF1EA-941D-42A0-99F1-16A21F780C8DQ28706276-1E321FF5-4020-49E7-BA1D-D8C536F4BDA9Q28829017-85B39EF3-32F9-43B2-A712-38C4169A64C7Q30596704-158C8AE3-BC05-488D-BC8B-59DDE1AE3A99Q31158830-8E1AF584-85BA-42C0-979D-3D00347625E9Q33602553-81F2C08E-399A-4F8D-A587-5FD42878804EQ33627888-BB72389D-6738-4550-B8CC-F953CA628C07Q33689071-34E81704-DA51-4077-925C-1DF421C42702Q33861296-B6F832D8-FE6B-4013-9C8B-1311AB1B6836Q34193741-88701B0A-3E2E-4924-84CB-8307E8D2CAEFQ34508935-C9E00E9E-DC9B-4F26-9563-501123756DD5Q35108153-C4446DC4-8AC3-49F8-9F44-9AA79F3AF757Q35186642-C0438C07-074E-4796-A2B5-F119E0ED4A73Q35592570-2AA46EAE-DA9F-481F-B399-D4277C712AB8Q35671261-50C20CF6-124A-4B99-97D5-F43A66A69D93Q36041530-7E0AB595-9E6B-41AE-B029-CC3F48397C26Q36189018-A997D146-7C84-4A2E-969A-2616A95333A3Q36273891-EB9D8B48-156B-47E0-9CD9-2F3F253FCD03Q36284267-2DEC71CF-CBD4-41D7-897D-1183D5E9F85DQ36335981-F53EFBE2-DF5D-400D-996F-2C1BFA7FE4B6Q36545216-479FD5C0-65E7-4305-BEF1-8C830291A191Q36629578-733BB97E-F042-4F0D-B6C9-764BAE3D4FB8Q36915887-0F3CAE01-87D0-494A-9FBC-3930E81BE743Q37084405-F1707558-BBFD-4162-AFED-7DC0A0A1DCE3Q37121662-44FC8290-857F-444F-8D89-087A87B31191Q37183663-A9440470-AFDA-4559-B0A0-6C233538136FQ37190973-0C3017C9-551A-4A57-8B38-B4F4C9A6ACD3Q37285224-3065A5DB-7B22-4089-A9EB-B6C89B0083CEQ37406819-B72B7F7D-FF37-47D6-A274-957AA1A20369Q37584073-8BF77D23-61F5-4B5E-85A2-FBA02A7285FBQ37627678-530A51B5-521E-49BE-BCCB-3C49B9A34112Q37687390-A7000A36-3056-4713-862F-AF7E11EA366AQ38088117-A5B38060-8230-4C7A-B1A8-6EE611700450Q38135859-C7089035-8D82-463F-8ECC-3861D99D230BQ38207943-E9E8D6FA-69AC-4A5C-B982-988DE4D9B642Q38287959-5E247126-ADFC-48DA-AE7C-15B7503AB098Q38359738-1568F2EF-771B-4C6B-A03B-85D018566BDFQ38570549-09474C33-21EA-4DDA-B547-D78CC7B428E0
P2860
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Breast cancer resistance prote ...... lation of its gene expression.
@en
type
label
Breast cancer resistance prote ...... lation of its gene expression.
@en
prefLabel
Breast cancer resistance prote ...... lation of its gene expression.
@en
P2860
P921
P356
P1476
Breast cancer resistance prote ...... ulation of its gene expression
@en
P2093
Douglas D Ross
P2860
P356
10.5732/CJC.011.10320
P5008
P577
2011-11-18T00:00:00Z